Type-2 diabetes prevalence and severity of Parkinson’s disease at a tertiary hospital
Mahmoud Abdullah Alzahrani, Marshad Abdullah Almutairi, Khulood Abdullah Alsiary, Sharifah S. Alshehrie, Hind M. Aljabri, Turki A. Alsaiari, Afnan S. Aghashami, Nabil Al-zahrani, Abdullah S. Badahda, Amal Saeed Alomri.
Abstract
Objective: To study the prevalence of type-2 diabetes mellitus (T2DM) in patients diagnosed with Parkinson’s disease (PD) and determine the impact of managing T2DM on the severity of PD symptoms.
Methods: A retrospective cohort review was carried out at King Abdulaziz Medical City, Ministry of National Guards-Health Affairs (KAMC-NGHA) in Jeddah, Saudi Arabia, from February to September 2023. The study included all PD patients who were admitted to KAMC-NGHA. The participants were divided into two groups: those with diabetes mellitus (DM) and those without DM. In the diabetes group, the patients were further classified as controlled and uncontrolled diabetes based on glycated hemoglobin (HbA1C) levels, specifically targeting a threshold of 7.0%.
Results: Of the 225 total PD patients, 145 (64.4%) had diabetes, while 80 (35.6%) did not. According to the Hoehn and Yahr (H&Y) scale, stage 5 PD was prevalent in both the diabetic and non-diabetic groups. When comparing controlled and uncontrolled diabetic patients, a statistically significant difference in the severity of PD was found (p = 0.029).
Conclusion: The study showed a significant extent of T2DM among PD patients. Moreover, an obvious difference in the severity of PD was spotted in individuals with diabetes, especially when comparing controlled and uncontrolled DM.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
